These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32492288)

  • 1. Enantiomerically Pure Quinoline-Based κ-Opioid Receptor Agonists: Chemoenzymatic Synthesis and Pharmacological Evaluation.
    Martin B; Schepmann D; Bernal FA; Schmidt TJ; Che T; Loser K; Wünsch B
    ChemMedChem; 2020 Aug; 15(15):1408-1420. PubMed ID: 32492288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Pharmacological Evaluation of Fluorinated Quinoxaline-Based κ-Opioid Receptor (KOR) Agonists Designed for PET Studies.
    Tangherlini G; Börgel F; Schepmann D; Slocum S; Che T; Wagner S; Schwegmann K; Hermann S; Mykicki N; Loser K; Wünsch B
    ChemMedChem; 2020 Oct; 15(19):1834-1853. PubMed ID: 33448685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological evaluation of enantiomerically pure
    Jonas H; Aiello D; Frehland B; Lehmkuhl K; Schepmann D; Köhler J; Diana P; Wünsch B
    Org Biomol Chem; 2021 Oct; 19(38):8384-8396. PubMed ID: 34528988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors.
    Grimwood S; Lu Y; Schmidt AW; Vanase-Frawley MA; Sawant-Basak A; Miller E; McLean S; Freeman J; Wong S; McLaughlin JP; Verhoest PR
    J Pharmacol Exp Ther; 2011 Nov; 339(2):555-66. PubMed ID: 21821697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipase-catalyzed kinetic resolution as key step in the synthesis of enantiomerically pure σ ligands with 2-benzopyran structure.
    Knappmann I; Lehmkuhl K; Köhler J; Schepmann D; Giera M; Bracher F; Wünsch B
    Bioorg Med Chem; 2017 Jul; 25(13):3384-3395. PubMed ID: 28501431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Synthesis of Enantiomerically Pure Decahydroquinoxalines as Potent and Selective κ-Opioid Receptor Agonists with Anti-Inflammatory Activity in Vivo.
    Soeberdt M; Molenveld P; Storcken RP; Bouzanne des Mazery R; Sterk GJ; Autar R; Bolster MG; Wagner C; Aerts SN; van Holst FR; Wegert A; Tangherlini G; Frehland B; Schepmann D; Metze D; Lotts T; Knie U; Lin KY; Huang TY; Lai CC; Ständer S; Wünsch B; Abels C
    J Med Chem; 2017 Mar; 60(6):2526-2551. PubMed ID: 28218838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformationally restricted κ-opioid receptor agonists: Synthesis and pharmacological evaluation of diastereoisomeric and enantiomeric decahydroquinoxalines.
    Molenveld P; Bouzanne des Mazery R; Sterk GJ; Storcken RP; Autar R; van Oss B; van der Haas RN; Fröhlich R; Schepmann D; Wünsch B; Soeberdt M
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5326-30. PubMed ID: 26411794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylated analogues of methyl (R)-4-(3,4-dichlorophenylacetyl)- 3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate (GR-89,696) as highly potent kappa-receptor agonists: stereoselective synthesis, opioid-receptor affinity, receptor selectivity, and functional studies.
    Soukara S; Maier CA; Predoiu U; Ehret A; Jackisch R; Wünsch B
    J Med Chem; 2001 Aug; 44(17):2814-26. PubMed ID: 11495592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformationally constrained kappa receptor agonists: stereoselective synthesis and pharmacological evaluation of 6,8-diazabicyclo[3.2.2]nonane derivatives.
    Geiger C; Zelenka C; Lehmkuhl K; Schepmann D; Englberger W; Wünsch B
    J Med Chem; 2010 May; 53(10):4212-22. PubMed ID: 20441176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Interaction Between Butorphanol and κ-Opioid Receptor.
    Ji J; Lin W; Vrudhula A; Xi J; Yeliseev A; Grothusen JR; Bu W; Liu R
    Anesth Analg; 2020 Sep; 131(3):935-942. PubMed ID: 32701545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoenzymatic Synthesis of Optically Active Ethereal Analog of
    Borowiecki P
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 8-aminomorphans with high KOR affinity.
    Jonas H; Aiello D; Schepmann D; Diana P; Wünsch B
    Eur J Med Chem; 2022 Feb; 230():114079. PubMed ID: 35033825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective synthesis and structure-affinity relationships of bicyclic kappa receptor agonists.
    Kracht D; Rack E; Schepmann D; Fröhlich R; Wünsch B
    Org Biomol Chem; 2010 Jan; 8(1):212-25. PubMed ID: 20024152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy.
    Béguin C; Potter DN; Dinieri JA; Munro TA; Richards MR; Paine TA; Berry L; Zhao Z; Roth BL; Xu W; Liu-Chen LY; Carlezon WA; Cohen BM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):188-95. PubMed ID: 17951511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of cyclohexane and piperazine based κ-opioid receptor agonists: Synthesis and pharmacological evaluation of trans,trans-configured perhydroquinoxalines.
    Bourgeois C; Werfel E; Schepmann D; Wünsch B
    Bioorg Med Chem; 2014 Jul; 22(13):3316-24. PubMed ID: 24856182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
    Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N
    J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 7,9-diazabicyclo[4.2.2]decanes as conformationally restricted κ receptor agonists: fine tuning of the dihedral angle of the ethylenediamine pharmacophore.
    Sunnam SK; Rack E; Schepmann D; Wünsch B
    Eur J Med Chem; 2011 Jun; 46(6):1972-82. PubMed ID: 21481987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of a carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalization.
    McLaughlin JP; Xu M; Mackie K; Chavkin C
    J Biol Chem; 2003 Sep; 278(36):34631-40. PubMed ID: 12815037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.
    Schattauer SS; Kuhar JR; Song A; Chavkin C
    Cell Signal; 2017 Apr; 32():59-65. PubMed ID: 28088389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).
    van Vliet LA; Rodenhuis N; Dijkstra D; Wikström H; Pugsley TA; Serpa KA; Meltzer LT; Heffner TG; Wise LD; Lajiness ME; Huff RM; Svensson K; Sundell S; Lundmark M
    J Med Chem; 2000 Jul; 43(15):2871-82. PubMed ID: 10956195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.